Background: There may be sex-specific cardiometabolic mechanisms early in life that affect the development of type 2 diabetes mellitus (T2DM) through mid-adulthood. However, few studies have examined whether early life course interactions between cardiometabolic risk factors and sex are associated with incident T2DM. Methods: This study followed 7725 children (3834 [49.6%] females, 3891 [50.4%] males) from the Bogalusa Heart Study through mid-adulthood to examine whether low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), body mass index (BMI), or systolic blood pressure (SBP) differentially affect the risk of T2DM for females versus males. Potential sex interactions were tested after adjusting for age, race, triglycerides, smoking, follow-up time, puberty stage, use of birth control, and enrollment year. Results: Mean (AE SD) age at baseline was 9.4 AE 3.5 years. There were 176 cases of T2DM (cumulative incidence = 2.3%) during a median follow-up of 9.1 years. In females versus males, LDL-C and SBP were differentially associated with T2DM (P ≤ 0.001 and P = 0.017, respectively). The relationships of BMI and HDL-C with T2DM were non-differential between females and males (P = 0.79 and P = 0.27, respectively). Conclusions: This study is the first to show evidence of sex-specific differential effects of LDL-C and SBP on the risk of T2DM from childhood to adulthood. Greater LDL-C places girls at disproportionally higher risk of T2DM as women, whereas greater SBP differentially exposes boys to a greater risk of T2DM as men. Additional studies within existing child cohorts are needed to confirm and investigate the mechanisms underlying these differential effects.
Introduction
Type 2 diabetes mellitus (T2DM) and cardiovascular disease are known to share many common risk factors, including obesity, hypertension, unbalanced lipid profiles, poor diet, and inadequate physical activity. [1] [2] [3] Although the sex-specific prevalence of T2DM is estimated to be approximately 10-12% among both men and women in the US, 4 substantial evidence has been summarized by the American Heart Association indicating worse outcomes, such as increased cardiovascular morbidity and mortality, for women compared with men with T2DM. 4 Furthermore, several observational studies have indicated differences in the effects of certain cardiometabolic risk factors on diabetes in women versus men. [5] [6] [7] Specifically, the Framingham Study indicated that increasing high-density lipoprotein cholesterol (HDL-C) reduced the risk of diabetes in elderly men but not women, 5 whereas the Finnmark 6 and MONICA (Multinational MONItoring of trends and determinants in CArdiovascular disease) 7 studies found the opposite result in middle-aged adults. The Finnmark and MONICA studies also showed that an increase in body mass index (BMI) differentially increased the risk of diabetes for men versus women. 6, 7 However, the results of these three studies conflicted with regard to whether systolic blood pressure (SBP) had a differentially adverse effect on women, men, or neither in terms of the risk of diabetes. Because these studies were performed on middle-aged or elderly populations, and because many of the sex-specific differences in diabetes are thought to be driven by interactions between cardiometabolic profiles, obesity, and sex, there may be similar mechanisms involved earlier in life that can be identified or observed prior to clinical diagnosis of T2DM. 4, 8 Therefore, the aim of the present study was to use early life course data to explore whether lipoprotein profiles, SBP, or obesity differentially affect the development of T2DM by sex beginning in childhood within the Bogalusa Heart Study (BHS).
Methods

Study design and population
The BHS started in 1973 under Dr Gerald Berenson, and consists of a series of long-term prospective studies of a semirural, biracial community in Bogalusa (LA, USA). Summarily, the BHS cohort consists of participants enrolled in childhood through cross-sectional cardiovascular risk factor surveys. After the initial childhood survey, study participants remain enrolled and complete cross-sectional surveys of cardiovascular risk factors every few years. Further details regarding the study population and design are described in greater detail elsewhere. 9 Demographic information, such as age, sex, and race, is collected through self-reported survey response or direct interview. Questions on tobacco use were asked for 3rd graders and older from 1974 onward.
We initially considered all participants (n = 7982) of the Bogalusa Heart Study who had at least one followup visit after the initial enrollment visit. We then excluded those with missing information for both diabetes diagnosis and glucose measurements (n = 212), those who already had a diabetes diagnosis upon enrollment (n = 20), and those with type 1 diabetes (n = 25). For participants who experienced the study outcome of incident T2DM, any subsequent study visits after the visit in which incident diabetes occurred were also excluded. The final study population consisted of 7725 participants from 1973 through 2010.
Exposure ascertainment and definitions
Current smoking status was ascertained through selfreport and was defined as any use of cigarettes within the past week. Systolic blood pressure levels were recorded as the first Korotkoff phase using mercury sphygmomanometers, and were reported as the mean of six repeated readings from two randomly assigned observers using the right arm of participants seated in a relaxed position. Serum cholesterol levels were obtained and assayed using documented enzymatic procedures. 10 Height and weight were also measured and averaged between two observers, with BMI calculated in the standard format of body weight (kg) per height (m) squared.
Outcome ascertainment and definition
Incident T2DM was determined to occur at any followup visit in which the participant was currently taking oral diabetes medication, had a current diagnosis of T2DM, and/or had a fasting blood glucose measurement >126 mg/dL.
Statistical analysis
Baseline cardiometabolic risk factors were tabulated and differences between female and male participants were compared using Pearson's Chi-squared P-values for categorical variables, Student's t-tests for normally distributed continuous variables, and Wilcoxon ranksum tests for skewed continuous variables. Data are presented throughout the text as mean AE SD, median with interquartile range (IQR) or as numbers with percentages.
Based on relationships between sex and diabetes risk factors suggested in previous studies, [5] [6] [7] we tested four plausible interactions with sex, namely low-density lipoprotein cholesterol (LDL-C), HDL-C, BMI, and SBP, for significant associations with incident T2DM over the life course. Data from each participant visit was combined into a logistic generalized estimating equations (GEE) model adjusted for race, age, triglycerides, current smoking status, time between visits, puberty status (Tanner Stages I-V), the use of oral contraceptives, and year of first visit (to remove any potential period effect). The outcome (dependent) variable in this model was incident T2DM at time of visit (yes/no), and the exposure variables in the model were sex, HDL-C, LDL-C, BMI, SBP, and the four individual interaction terms between sex and each exposure. All GEE models used an unstructured covariance matrix to allow flexibility and to prevent the introduction of bias from incorrect assumptions of the covariance structure.
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Multiple imputation using Markov chain Monte Carlo estimation was used to impute all missing covariate measurements (327 visits [1.1%] were missing at least one covariate measurement).
Results
Of the 7725 participants, 3834 (49.6%) were female and 3891 were male (50.4%). The mean age of participants at enrollment was 9.4 AE 3.5 years. There were 176 participants with incident T2DM (cumulative incidence = 2.3%) during a median follow-up of 9.1 years in which study participants combined for a total of 30 959 study visits (mean 4.0 per participant). At baseline, boys had significantly higher SBP, HDL-C, and glucose levels, and were more likely to be smokers than girls (Table 1) . Conversely, girls had significantly greater LDL-C and triglycerides at baseline. At follow-up, there was no significant difference in the cumulative incidence of T2DM for girls (2.4%) versus boys (2.1%; P = 0.39), although men and women differed significantly in their risk factor profiles: men had greater SBP and glucose, whereas women had higher BMI, LDL-C, and HDL-C (Table 1) .
In the adjusted GEE model, most of the traditional cardiometabolic risk factors were significant predictors of incident diabetes (Table 2) . Notably, those of black race had an adjusted odds ratio (OR) for diabetes of 1.57 (95% confidence interval [CI] 1.11, 2.22; P = 0.011), and each 50 mg/dL increase in triglycerides corresponded to an adjusted OR for diabetes of 1.13 (95% CI 1.08, 1.18; P < 0.0001). The relationship between BMI and diabetes was significant (P < 0.0001) and non-linear, and is shown in Fig. 1 . However, this relationship was non-differential between females and males (P interaction = 0.79). Similarly, HDL-C was significantly associated with diabetes (P < 0.001) in a nondifferential (P interaction = 0.27), non-linear trend ( Fig. 1) . In contrast, LDL-C and SBP were both differentially associated with diabetes (P interaction < 0.001 and P interaction = 0.017, respectively) in females versus males. In males, increasing SBP substantially increased the risk of diabetes, whereas in females an increasing SBP did not change the risk of diabetes (Fig. 2) . Conversely, an increasing LDL-C increased the risk of diabetes in women, but slightly lowered the risk of diabetes in men (Fig. 3) .
Discussion
The present study is the first to assess differential sexspecific effects of cardiometabolic risk factors on incident T2DM in large cohort using a life course approach from childhood. The analysis shows strong evidence that early life interaction between LDL-C and sex is associated with incident T2DM; an increase in LDL-C through adolescence puts women at greater risk of diabetes, but may actually reduce the risk of diabetes in men. In addition, we have shown that increasing SBP is an important T2DM risk factor for men, yet has almost no effect on the development of T2DM in women. Although greater BMI and HDL-C values were also significant life course risk factors for T2DM in both females and males, we found no evidence of a differential role of these risk factors between sexes.
The most comparable study to date for assessing childhood risk factors of adult diabetes was the Princeton-lipid research clinics follow-up study, 12 although the results were not stratified or tested for sex differences. In Princeton, Morrison et al. 12 found a marginally significant effect of high SBP (defined as ≥90th age-height-specific percentile) on diabetes (OR = 1.82; 95% CI 0.98, 3.41). Conversely, previous studies comparing sex differences in cardiometabolic risk factors for incident diabetes have included the Framingham, 5 Finnmark, 6 and MONICA Augsberg 7 studies, although these studies were conducted in adult populations without prospective childhood data. In the Framingham study, 5 SBP was not significantly associated with diabetes in elderly men or women, whereas SBP was associated with diabetes for women only in the Finnmark study. 6 However, the MONICA investigators found results similar to those of the present study: SBP was a significant predictor of diabetes for men, but not for women in their cohort. 7 The MONICA authors acknowledged this finding could be due to more women in their study having controlled hypertension than men. The cohort in the present study is unlikely to be affected by this discrepancy because very few of the participants are taking hypertension medication at young ages. Similarly, there is evidence showing that hypertension is disproportionately associated with metabolic syndrome in men 13 and that hypertension is more frequently clustered with other metabolic syndrome factors, such as low HDL-C and increased triglycerides, in young males.
14 Several shared pathways have been identified to link hypertension and diabetes, including genetics, insulin resistance, sex hormones, central obesity, oxidative stress, and physical activity, 15 and it is very possible that some combination of these factors behaves differently in adolescents compared with adults.
The results of the lipoprotein analysis in the present study show that an increase in LDL-C is associated with a greater risk of diabetes in young women, whereas the inverse of this relationship is true for young men. This result is intriguing given the prevailing knowledge that although increased levels of very small, dense LDL-C particles are associated with diabetes, overall LDL-C levels are not typically associated with diabetes. [16] [17] [18] One reason for this discrepancy may be that most studies have not looked for differential effects by sex. For example, the overall effect of LDL-C on diabetes may be null when both sexes are combined, but this may conceal the increased risk among women and decreased risk among men at high LDL-C that was seen in the present cohort due to our intentional search for this interaction. Furthermore, the Princeton study found no difference in risk for those with high LDL-C versus low LDL-C when defined as ≥110 mg/dL (OR = 0.95; 95% CI 0.65-1.44), but this dichotomization of LDL-C may have inhibited their ability to find a true significant effect. 19, 20 Indeed, the present study indicates that the lowest risk of diabetes may actually be near this 110 mg/dL cut-off for both men and women, with risks increasing to the extremes at either side for women (Fig. 3) . In fact, a previous analysis from Bogalusa also showed that an 18-mg/dL childhood increase in LDL-C raised the risk of young adult prediabetes by 40%. 21 An increase in the risk of incident diabetes was seen in the data in the present study for both men and women as LDL-C decreased below approximately 90 mg/dL. This is consistent with previous evidence from meta-analyses showing that LDL-lowering therapies and alleles associated with LDL lowering are associated with increased risk of diabetes. 22, 23 However, in the present study this effect was seen in women only at lower LDL-C levels versus across all LDL-C levels in men; the relationship was Ushaped for women and L-shaped for men (Fig. 3) .
Similar to the Princeton follow-up study, 12 which indicated a 63% higher risk of diabetes for those with a low compared with high HDL-C, we also detected a strongly increasing risk of diabetes for both men and women with low HDL-C levels. Most surprising was our result that the effect of HDL-C on the risk of diabetes did not appear to differentiate by sex. Previously, when assessing sex differences, the Finnmark 6 and MONICA 7 studies found greater HDL-C to be more beneficial in lowering the risk of diabetes for females, whereas the Framingham 5 study found HDL-C to be Figure 1 Non-differential adjusted probabilities of type 2 diabetes mellitus (T2DM) by high-density lipoprotein cholesterol (HDL-C) and body mass index (BMI). Life course-predicted probabilities of diabetes by HDL-C and BMI with no sex interaction. Adjusted for race, age, triglycerides, current smoking status, time between visits, puberty status, use of oral contraceptives, year of first visit, lowdensity lipoprotein cholesterol, and systolic blood pressure.
protective of diabetes in males only. However, because the Finnmark, 6 Framingham, 5 and MONICA 7 studies considered only HDL-C, and did not adjust for LDL-C, it is possible that in the present study the finding of a strong differential effect of LDL-C overwhelmed a smaller HDL-C interaction effect.
As expected, we found a significant increase in young adult T2DM risk with increasing childhood BMI, which has been regarded as a driving factor in the decadeslong increase in the prevalence of childhood diabetes across the US. 24, 25 With regard to our finding of no differential effects of BMI by sex, our results differ from those of both the MONICA study, 7 in which a 4-kg/m 2 increase in BMI resulted in a twofold increase in the risk of diabetes for men compared with women (OR = 1.98 and 1.49, respectively), and the Finnmark study, 6 which also showed a more adverse effect of BMI on diabetes for men. However, given the younger nature of the population in the present study, it is plausible that the cumulative effects of obesity over the life course become differentiated only after several decades of exposure. A good example of this phenomenon comes from our finding that cigarette smoking among children had virtually no effect on diabetes risk in young adulthood (OR = 0.92; 95% CI 0.64, 1.34). Although it has been extensively documented that smoking increases the risk of diabetes in both men and women, [26] [27] [28] [29] [30] the cumulative effect of smoking (e.g. packyears) on diabetes may be too low, or the latency period may be too long, for smoking to contribute to diabetes in late adolescence or young adulthood. It has been Differential adjusted probabilities and relative odds of type 2 diabetes mellitus (T2DM) by systolic blood pressure (SBP). Life course-predicted probabilities and odds ratios (OR) with 95% confidence intervals (CI) comparing females and males according to SBP with P-values for sex interaction. Adjusted for race, age, triglycerides, current smoking status, time between visits, puberty status, use of oral contraceptives, year of first visit, body mass index, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. 
Figure 3
Differential adjusted probabilities and relative odds of type 2 diabetes mellitus (T2DM) by low-density lipoprotein cholesterol (LDL-C). Life course-predicted probabilities and odds ratios (OR) with 95% confidence intervals (CI) comparing females and males by LDL-C with P-values for sex interaction. Adjusted for race, age, triglycerides, current smoking status, time between visits, puberty status, use of oral contraceptives, year of first visit, body mass index, high-density lipoprotein-cholesterol, and systolic blood pressure.
shown that the latent period for smoking and certain types of cancer can exceed 30-40 years, for example. 31 The present study has some limitations. First, the continuous enrollment period and follow-up schedule of the study necessitates that not all the study cohort was enrolled as children in the same year. For this reason, we have controlled for the year of enrollment to eliminate the bias from any period effect that likely exists, given the increasing prevalence of childhood and young adult diabetes during the study period. Indeed, we found an approximate 4% increase in the risk of diabetes with each successive year of enrollment. Second, although all subjects had at least one subsequent follow-up visit in addition to the enrollment visit, many subjects had several additional visits that were also included in the model to increase power and precision. Thus, it is also possible that differential visits occurred; for example, a greater number of visits for healthier subjects per the healthy user effect. We conducted sensitivity analysis of missing visits by retaining only the enrollment visit and the most recent visit for all subjects, and the results were extremely similar to those of the main analysis in both effect size and significance (see Appendix I), showing that inclusion of multiple visits added precision to our estimates and was unlikely to have biased our results. Third, due to slight differences in cigarette smoking questions asked over several decades of the study, our definition of current smoking as ≥1 cigarette per week is open to the potential of residual confounding or misclassification. However, the young age of our cohort and low prevalence of smoking (2.7% at baseline) likely reduces the magnitude that any misclassification could have had on our results. Fourth, our analysis tested four distinct hypotheses; therefore, a conservative approach would have been to apply a Bonferroni correction for multiple testing. Nevertheless, given that these tests were not truly independent, but were conducted within the same model and likely to be highly correlated with each other, Bonferroni correction is likely to be too conservative. Therefore, considering this limitation of correction for multiplicity, along with the fact that these four hypothesis tests were specified a priori, we chose not to adjust for multiple testing in our main results, which could have slightly increased the chances of a false positive finding. Finally, residual confounding is always a possibility in an observational study, and causality cannot be inferred from an observational design regardless of control for confounding. Nevertheless, we have controlled for age, race, BMI, smoking, LDL-C, HDL-C, SBP, triglycerides, use of contraceptives, pubertal status, and followup time in our final model. These variables are inclusive of those most often and most strongly associated with cardiometabolic disease and diabetes. Therefore, additional confounding from unconsidered variables is likely to have a limited effect on these results.
In summary, the present study is the first to investigate and provide evidence of sex-specific differential effects of LDL-C and SBP on the risk of T2DM from childhood to mid-adulthood. A greater LDL-C appears to put girls at disproportionally higher risk of T2DM as women, whereas a higher SBP differentially exposes boys to a greater risk of T2DM as men. Conversely, greater BMI and lower HDL-C put both girls and boys at a non-differential but still increased risk of adult diabetes. Additional studies in similar child cardiovascular cohorts are needed to confirm and investigate the mechanisms underlying these differential effects.
